Where does Piramal Enterprises Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Piramal Enterprises Limited ranks #9,587 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Piramal Enterprises Limited hold?

Piramal Enterprises Limited holds 33 US utility patents granted between 2015 and 2025, spanning 12 technology areas.

What is Piramal Enterprises Limited's Innovation Score?

Piramal Enterprises Limited has an Innovation Score of 35.9 out of 100 (top 48% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Piramal Enterprises Limited focus on?

Piramal Enterprises Limited's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 28 patents, ranking #708 of 6,058 assignees active in that subclass. Grants appear in 12 CPC subclasses total.

Is Piramal Enterprises Limited's patent grant rate increasing or decreasing?

Piramal Enterprises Limited's recent grant velocity is -18% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Piramal Enterprises Limited's patents?

Piramal Enterprises Limited's patents average 14.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Piramal Enterprises Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Piramal Enterprises Limited

USPTO PatentsView assignee record - 33 granted patents across 12 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Piramal ranks #9,587 of 49,997 tracked US assignees by granted-patent volume, with 33 patents across 12 technology areas.

#9,587
of 49,997 US assignees by volume: Top 48%
by Innovation Score (35.9/100): 14.6
avg claims per patent: -18%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9587 · Foreign Corporation #9,587 · 33 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 33 grants
UPPER-Q #9,587/49,997
PHOTO-FINISH Oath (Americas)
CPC-FOCUS A61P · 12 areas
INNOV-THIN 35.9/100
CLAIMS-RICH 14.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -18% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Oath (Americas) Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Piramal’s 35.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.2 pts (34%) Velocity 2.7 pts (8%) Breadth 12.2 pts (34%) Claim depth 8.8 pts (25%)

Qualcomm Incorporated · highest

85
Callwave Communicati… · near

36
Homecare Products · near

36
Piramal Enterprises · this assignee

36
QuiO · near

36
Vasona Networks · near

36
3D Lighting… · lowest

7

What this shows Piramal's Innovation Score is 35.9/100 (top 48% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Piramal?

Each dot is one of Piramal’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Piramal’s own 14.6 claims/patent is at or below the 16.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Piramal vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Piramal's grants concentrate

Piramal Enterprises Limited is a focused PatentsView assignee: 12 CPC subclasses with 84.8% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2019 (7 grants) versus a trough of 1 in 2017. By volume, Piramal sits between Oath (Americas) Inc. and Patreon, Inc..

Piramal's three-year grant acceleration

Piramal Enterprises Limited shows 6 grants in 2022–2024 against only 15 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Oath (Americas)

33
Optical Cable

33
Philogen S P A

33
Phinergy

33
Pure Depth

33
Pacific Handy Cut…

33
Par Pharmaceutical

33
Patreon

33
Piramal Enterpris… ◀

33

What this shows Piramal holds 33 patents at rank #9,583, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Piramal

By rank, the assignees closest to #9,583 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Piramal's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Piramal, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Piramal ranks #708 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (36 here).

Callwave Communications, LLC 36 Vasona Networks, Inc. 36 Homecare Products, Inc. 36 QuiO Technologies LLC 36

Piramal's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 48% higher than 52% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Piramal Enterprises Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	9.1%
2016	2	6.1%
2017	1	3.0%
2018	4	12.1%
2019	7	21.2%
2020	2	6.1%
2021	6	18.2%
2022	2	6.1%
2023	2	6.1%
2024	2	6.1%
2025partial year	2	6.1%

Which technologies does Piramal Enterprises Limited patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 28

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 23

C07D - Heterocyclic Compounds 17

C07C - Acyclic OR Carbocyclic Compounds 8

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 3

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 2

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 2

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 1

C07J - Steroids 1

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 1

C07K - Peptides 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Piramal Enterprises Limited's patent record in context - here's where to go next.

Piramal Enterprises Limited's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 84.8% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #9,587 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Piramal Enterprises Limited against Oath (Americas) Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.